The largest database of trusted experimental protocols

Stata se software

Manufactured by StataCorp
Sourced in United States

Stata/SE is a statistical software package developed by StataCorp. It is designed for advanced data analysis, modeling, and visualization. Stata/SE provides a wide range of statistical tools and capabilities for researchers, analysts, and professionals in various fields.

Automatically generated - may contain errors

68 protocols using stata se software

1

Immune Response Biomarker Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Correlations between variables were assessed by Spearman’s rank coefficient, with Benjamini-Hochberg correction for multiple comparisons. Continuous data were compared between matched case/control pairs by Sign-test and between non-paired groups by Mann-Whitney test. BoR was compared between groups by a Test for trend across ordered groups and between isolates transcribing var/DCs at low- or high-levels by negative binomial regression models adjusted by age. Mean ratio of IgGs and 95% confidence intervals between Mozambican children and Spanish adults, as well as between Mozambican children older than 2.5 years of age and less than 2.5 years were calculated in linear regression models, with log-transformed MFIs. Statistical analysis was performed with Stata/SE software (version 12.0; StataCorp).
+ Open protocol
+ Expand
2

Predictive Model for Newly Detected Atrial Fibrillation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Descriptive statistics were presented as frequencies, means and standard deviations, or medians and interquartile ranges (IQRs), as appropriate. The Kolmogorov-Smirnov test was used to examine the normality of continuous variables, which were then compared using a Student's t-test or Mann-Whitney U-test, as appropriate. Categorical data were analyzed using a chi-squared test or Fisher's exact test. All tests were two-tailed, and a p-value < 0.05 was considered to indicate a statistically significant difference.
Factors potentially associated with newly-detected AF were evaluated using descriptive statistics. Univariable logistic regression models were used to evaluate candidate variables. Odds ratios (ORs) together with 95% confidence intervals (CIs) were reported, and p-values < 0.05 were considered to indicate a statistically significant difference. We built a multivariable regression model based on all potential predictors using forward stepwise selection with p < 0.05. Then the “nomolog” package was used to establish a predictive model and generate the nomogram to predict newly detected AF. We also examined discrimination using the C-statistic in our regression model, CHA2DS2-VASc, CHARGE-AF, and EHR-AF scores. Analyses were performed using Stata SE software (version 15.1; StataCorp, College Station, TX).
+ Open protocol
+ Expand
3

Pooling Data for Survival Meta-Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
A random effects model was used for pooling data for survival. Interstudy heterogeneity was assessed with Cochran’s Q-test. The percentage of total variation across studies owing to heterogeneity was evaluated by the I2 measure. Owing to differences in defining and reporting adverse events (AEs) in the individual studies, pooling the data may have been misleading; therefore, safety was evaluated qualitatively. Pooled survival was estimated using StataSE software (StataCorp, College Station, TX).
+ Open protocol
+ Expand
4

Comprehensive Liver Cancer Mortality Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data merging and sorting were performed by using the Stata/SE software (Version: 16.0). Joinpoint regression analysis of liver cancer mortality was performed by the Joinpoint software (Version: 4.9.0.0). Regional distribution of liver cancer mortality was mapped by using the ArcGIS software (Version: 10.8.1). The GeoDa software (Version: 1.18.0) was used for global and spatial autocorrelation analysis. Significance level for all statistical tests or inferences was set as a two-tailed probability no higher than 0.05.
+ Open protocol
+ Expand
5

Gestational Hypertension and Vitamin D

Check if the same lab product or an alternative is used in the 5 most similar protocols
The distribution of outcomes and risk factors for both ethnic groups are presented as frequency (percentage), mean (SD) or median (IQR). Associations of 25(OH)D, PTH and calcium with gestational hypertension, pre-eclampsia and associated adverse outcomes were assessed using multinomial or logistic regression with the exposure as a continuous variable. Two models were considered for each outcome: model 1 was unadjusted, and model 2 was adjusted for the confounders described above. The physical activity questionnaire has four categories: inactive, moderately inactive, moderately active and active; however, due to low numbers in the ‘active’ category, this was merged with ‘moderately active’ for the analysis. Associations between the exposures and outcomes are presented as odds ratios per 1 standard deviation (SD) increase. The analysis was done for all women, and for White British and Pakistani women separately and tested for any differences in associations between the ethnic groups (i.e. tested for an interaction between ethnicity and exposure). All analyses were performed using STATA/SE software (Stata/SE 13.1 for Windows, StataCorp LP, College Station, TX, USA).
+ Open protocol
+ Expand
6

Stratified Analysis of LARC Provision

Check if the same lab product or an alternative is used in the 5 most similar protocols
Most survey items used 5-point Likert-type response scales. Because exploratory analyses showed bimodally distributed data for the majority of items, we created dichotomous variables by collapsing responses (“Not at All/Never/None,” “A Little/Rarely/Very Few,” and “Somewhat/Sometimes/Some” = −1; “Very/Often/Quite a Bit/Many,” and “Extremely/Very Often/A Great Deal/Most” = +1).
Given the large between-specialty differences in LARC provision, we stratified results by specialty. For relevant analyses, we also stratified within-specialty results by provider type comparing physicians and midwives. We used the National Center for Health Statistics classification system23 to classify respondents as urban or rural, based on the county in which they indicated seeing the most patients.
We used chi-square tests and 2-sample tests of proportions to compare outcomes by provider specialty and considered P-values <. 05 to be significant. All analyses were conducted using Stata SE software (version 14.1, StataCorp, College Station, Texas).
+ Open protocol
+ Expand
7

Meta-analysis of ER Antagonists

Check if the same lab product or an alternative is used in the 5 most similar protocols
Review Manager (RevMan) 5.3 software (Nordic Cochrane Centre) was used for all analyses. Relative risks with 95%CIs for dichotomous data and mean differences (MDs) with 95%CIs for continuous data were calculated. When applied scales differed, the standardized mean difference (SMD) was adopted instead of MDs. Heterogeneity test were conducted across studies using the Q-test and I2 statistic. If P value of Q-test was less than 0.1 and I2 value was less than 50%, statistically significant heterogeneity existed[11 (link)]. A random-effects model was used when obvious heterogeneity was present; otherwise, a fixed-effects model was chosen. Publication bias was assessed using the Egger’s test with Stata/SE software (version 15.1). P < 0.05 indicated a possibility for publication bias. Missing means were substituted with reported medians, while missing standard deviations were computed from confidence intervals, standard errors, t values, P values, or correlations evaluated from other enrolled studies[10 ]. All treatment dosages in the ER antagonist groups of each trial were integrated into one single group and compared to placebo if necessary. Combined data were analyzed using RevMan 5.3 software.
+ Open protocol
+ Expand
8

Estimating Risk Factors using RevMan 5.3

Check if the same lab product or an alternative is used in the 5 most similar protocols
We combined trial results for estimating risk factors using Review Manager 5.3 (RevMan 2012, http://tech.cochrane.org/revman/). We presented results as summary ORs or SMDs with 95% CIs.
Between-study heterogeneity was tested with the Cochrane Q test and I2 statistics. A P value of <0.05 for the Cochrane Q test was considered to indicate significant heterogeneity. An I2 value of >50% was considered to indicate significant heterogeneity. We used the random-effects model to calculate the ORs (or SMDs) and 95% CIs [19 (link)]. Publication bias was estimated with the Begg’s and Egger’s tests. A P value of <0.05 was considered statistically significant (Stata SE software, StataCorp, College Station, Texas).
+ Open protocol
+ Expand
9

Acoustic Neuroma Surgical Resection Predictors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data were collected using Research Electronic Data Capture (REDCAP; http://www.project-redcap.org) and analyzed using Stata SE software (version 13; Stata Corp; College Station, TX). Differences between demographic, clinical, and psychometric variables were analyzed using Student’s t test or nonparametric Wilcoxon rank-sum tests for continuous variables and cross tabulations, and using generalized chi-square or Fisher Exact tests for categorical variables. A multiple logistic regression model was created with the presence or absence of acoustic neuroma surgical resection as the dependent variable, and patient age, hearing classification, tumor grade, tumor growth status, headache severity scores, quality of life, depression, and self-esteem scores as the independent variables. The significance level was set at 0.05. To account for the possible influence of missing data, multiple imputation strategy was utilized demonstrating no significant difference in results or relationships on repeat analysis with imputed data.29 (link) Thus, the original multiple logistic regression model was used as described.
+ Open protocol
+ Expand
10

Breakfast Frequency, Insulin Resistance, and Dietary Intake

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analyses were carried out using STATA/SE software (STATA/SE 12 for Windows, StataCorp LP). Multilevel linear regression models were used to provide adjusted means (adjusted to the average level of each variable in the model, so that the values are close to the observed data) and to quantify the associations between breakfast frequency, risk markers, and dietary intake, using XTMIXED and LINCOM commands. All analyses were adjusted for sex, age in quartiles, ethnicity (in ten ethnic subgroups), day of week and month as fixed effects; school was fitted as a random effect to allow for the clustering of children within schools. No adjustments were made for multiple comparisons as a strong a priori hypothesis that both breakfast frequency and content will be associated with insulin resistance and glycaemia was to be tested.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!